Registry for advanced endoscopic procedures in gastrointestinal conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry collects data on patients undergoing endoscopic diagnostic and therapeutic interventions for conditions such as cholangiocarcinoma, pancreatic cancer, and sclerosing cholangitis. The study aims to document the outcomes and effectiveness of procedures like endoscopic retrograde cholangiopancreatography and endoscopic ultrasound. By gathering comprehensive data, the registry seeks to enhance understanding and improve future treatment strategies for these serious gastrointestinal diseases.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical indication for endoscopic intervention/procedure

Exclusion Criteria:

* No informed consent
* Age \<18 years

Where it's running

• Karolinska University Hospital
  Stockholm, Sweden Recruiting

Study contacts

• Principal investigator: Erik von Seth, MD, PhD — Region Stockholm
• Study coordinator: Erik von Seth, MD, PhD
• Email: erik.von.seth@ki.se
• Phone: +46812380000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• 68Ga-SorB PET/CT imaging for solid tumors

  This study tests a new PET tracer called 68Ga-SorB to see if it can safely and accurately detect tumors in adults with melanoma, liver, lung, breast, pancreatic, ovarian cancer, or cholangiocarcinoma.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT07760012

• CAIX-targeted 18F-T2 PET/CT imaging in solid tumors

  This study tests a CAIX-specific radioactive tracer to see if PET/CT can help visualize solid tumors and checks safety and radiation exposure in adults with certain cancers.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT07557225

• In-depth characterisation of biliary strictures and hepato‑pancreato‑biliary focal lesions to support new diagnostic technologies

  This project will collect detailed imaging and tissue data from adults with suspected bile duct, liver, pancreatic, or gallbladder lesions to help develop and test better diagnostic tools.

  Recruiting University of Nottingham · Nottingham · NCT07206355

• Tissue adhesive (Glubran®2) to reinforce pancreaticojejunostomy in soft pancreas

  This trial will test whether adding a tissue adhesive glue (Glubran®2) to the pancreatic-jejunal connection reduces postoperative pancreatic leaks in adults with a soft pancreas undergoing pancreaticoduodenectomy.

  Recruiting Minia University · Minya, Minya Governorate · NCT07155525

• Using bile analysis to diagnose unclear narrowings of the bile ducts

  This project will test whether analyzing bile with molecular 'omics' together with routine biliary brushings or biopsies can help find cancer in people with indeterminate biliary strictures.

  Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai, China · NCT07007832

• Testing MDX2001 for advanced solid tumors

  This study is testing a new drug called MDX2001 to see if it can safely help people with advanced solid tumors like breast or colon cancer.

  Recruiting at 6 sites Phase 1/2 ModeX Therapeutics, An OPKO Health Company · Denver, Colorado and 5 other locations · NCT06239194

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.